| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.TP.0000110295.88926.5C |
| P698 | PubMed publication ID | 14966415 |
| P50 | author | Hiroto Egawa | Q90581550 |
| P2093 | author name string | A M James Shapiro | |
| Koichi Tanaka | |||
| Hironori Haga | |||
| Fumitaka Oike | |||
| Tetsuya Kiuchi | |||
| Sachiko Minamiguchi | |||
| Leo Buhler | |||
| Kenji Uryuhara | |||
| Satoshi Kaihara | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 403-411 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. | |
| P478 | volume | 77 |
| Q41960411 | A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure |
| Q38422411 | ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab. |
| Q90705931 | ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes |
| Q41516975 | ABO-incompatible liver transplantation for severe hepatitis B patients |
| Q90005549 | ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer |
| Q46468627 | ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile |
| Q36206934 | Adult Living Donor Liver Transplantation Across ABO-Incompatibility |
| Q42792180 | Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients |
| Q33772091 | Analysis of complications in hepatic right lobe living donors |
| Q50114384 | Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients |
| Q40860739 | Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation. |
| Q40741639 | Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation |
| Q36746806 | Current trends in live liver donation |
| Q37105733 | Distribution of ABO blood group and major cardiovascular risk factors with coronary heart disease |
| Q53521067 | Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and resu |
| Q33425680 | Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation |
| Q38029570 | Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature |
| Q53539768 | Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation. |
| Q38478624 | Imaging of biliary complications in recipients of right-lobe living donor liver transplantation |
| Q92606381 | Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation |
| Q46198276 | Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. |
| Q43660500 | Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. |
| Q33381663 | Indication for splenectomy in the era of living-donor liver transplantation |
| Q35715908 | Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation |
| Q53832478 | Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. |
| Q51240343 | Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. |
| Q60932740 | Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study |
| Q46512704 | New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen |
| Q46453010 | New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange |
| Q39077368 | Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation |
| Q42695184 | Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis |
| Q51019320 | Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience. |
| Q51534497 | Pediatric patients receiving ABO-incompatible living related liver transplantation exhibit higher serum transforming growth factor-β1, interferon-γ and interleukin-2 levels |
| Q81422881 | Present status of ABO-incompatible living donor liver transplantation in Japan |
| Q50484739 | Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice. |
| Q50632752 | Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. |
| Q80151835 | Significance of C4d staining in ABO-identical/compatible liver transplantation |
| Q57153864 | Single-center experience and long-term outcomes of duct-to-duct biliary reconstruction in infantile living donor liver transplantation |
| Q48374184 | The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience |
| Q79439021 | The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation |
| Q46631784 | Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation |
| Q46924230 | Use of ABO-incompatible grafts in living donor liver transplantation--first report from India |
Search more.